Investigators recently inspected the company’s facility and found poor sterile production practices, which resulted in the initial product alert. This week that alert was expanded.
The agency has not learned of any adverse events from improperly sterilized NuVision products. The alert is cautionary.
More Articles on Anesthesia:
FDA Changes Label, Lowers Dose Recommendation for Zolpidem Insomnia Drug
Masimo Announces Clinical Study Outcomes at International Anesthesia Research Society Meeting
Physician Office Partners Releases Billing Solution for Anesthesia Practices
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Legal & Regulatory Issues
-
Adult medical specialties posted the largest increase in median work relative value unit productivity from 2025 to 2026, the second…
-
A coalition of five Medicaid beneficiaries, six physician and health organizations and the city of Columbus, Ohio, sued HHS Secretary…
-
The Wake County (N.C.) board of commissioners voted 5-2 on Sept. 21 to approve the proposed combination of Raleigh, N.C.-based…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
